My watch list
my.bionity.com  
Login  

Alzheimer’S Disease

News Alzheimer’S Disease

  • Protein-folding simulations sped up

    Proteins, the ubiquitous workhorses of biochemistry, are huge molecules whose function depends on how they fold into intricate structures. To understand how these molecules work, researchers use computer modeling to calculate how proteins fold. Now, a new algorithm can accelerate those vital simulat more

  • New details on aged brain, Alzheimer's and dementia revealed

    In a comprehensive analysis of samples from 107 aged human brains, researchers at the Allen Institute for Brain Science, UW Medicine and Kaiser Permanente Washington Health Research Institute have discovered details that will help researchers better understand the biological bases for Alzheimer's di more

  • Mechanism explains how seizures may lead to memory loss

    Although it's been clear that seizures are linked to memory loss and other cognitive deficits in patients with Alzheimer's disease, how this happens has been puzzling. In a study a team of researchers reveals a mechanism that can explain how even relatively infrequent seizures can lead to long-lasti more

All news on alzheimer’s disease

Videos Alzheimer’S Disease

Chaperones - folding helpers in the cell

Nothing works without the correct form: For most proteins, there are millions of ways in which these molecules, composed of long chains of amino acids, can be folded - but only one way is the right one. Researchers in the department "Cellular Biochemistry" at the Max Planck Institute for Biochem ... more

Events Alzheimer’S Disease

Conference
05-03 – 08-03
2018
Cancún, MX

Genomic Instability and Gene Therapeutics in Neurological Diseases Conference

With the rapidly emerging new tools including genomics, bioinformatics, metabolomics and proteomic analysis and new powerful editing tools such as CRISPR/CAS9 we are getting closer to more defined understanding of the complex cellular pathways underpinning neurodegeneration, which underlie many debi

Conference
01-06 – 04-06
2018
Nassau, BS

Targeting Therapy of Alzheimer’s and Related Neurodegenerative Diseases

Alzheimer’s disease (AD) is the most common age-dependent neurodegenerative disease, which affects over 5 million people in the US and over 35 million people worldwide. Currently, only four drugs are approved for alleviating symptoms in AD patients, and no new therapy has been approved for AD since

Webinar
On-Demand

Characterization of AD Animal Models: Building In Vivo Tools to Assess Next-Generation AD Therapeutics

Preclinical development of drug candidates for Alzheimer’s disease (AD) takes multiple different paths; animal models are indispensable tools to support diverse preclinical drug development programs. Charles River performs in-house evaluations employing several mouse models of AD using a range of up

Publications Alzheimer’S Disease

All publications on alzheimer’s disease
Related topics
Definition

Alzheimer's disease

Alzheimer's disease Alzheimer's disease (AD), also called Alzheimer disease, and simply known as Alzheimer's, is a neurodegenerative disease that, in its most common form, is found in people over the age of 65. Approximately 24 million people ... more

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE